Capricor Therapeutics, Inc

(NASDAQ:CAPR)

Latest On Capricor Therapeutics, Inc (CAPR):

Date/Time Type Description Signal Details
2023-05-12 07:12 ESTNewsCapricor Therapeutics, Inc. (CAPR) Q1 2023 Earnings Call TranscriptN/A
2023-05-11 17:36 ESTNewsCapricor Therapeutics GAAP EPS of -$0.31 beats by $0.01, revenue of $2.98M beats by $2.48MN/A
2023-03-16 00:26 ESTNewsCapricor Therapeutics GAAP EPS of -$0.31 beats by $0.03, revenue of $0.96M beats by $0.96MN/A
2023-03-16 00:26 ESTNewsCapricor Therapeutics, Inc. (CAPR) Q4 2022 Earnings Call TranscriptN/A
2023-03-14 18:00 ESTNewsCapricor Therapeutics Q4 2022 Earnings PreviewN/A
2023-01-25 14:41 ESTNewsCapricor stock falls amid data for duchenne muscular dystrophy studyN/A
2022-11-11 07:18 ESTNewsCapricor Therapeutics GAAP EPS of -$0.26 beats by $0.05, revenue of $1.59M beats by $1.45MN/A
2022-11-11 07:17 ESTNewsCapricor Therapeutics, Inc. (CAPR) Q3 2022 Earnings Call TranscriptN/A
2022-11-09 21:36 ESTNewsCapricor Therapeutics Q3 2022 Earnings PreviewN/A
2022-08-12 00:03 ESTNewsCapricor stock rises 16% after update on muscular dystrophy treatment, Q2 resultsN/A
2022-08-11 07:06 ESTNewsCapricor Therapeutics GAAP EPS of -$0.29 misses by $0.03N/A
2022-08-11 07:06 ESTNewsCapricor Therapeutics, Inc. (CAPR) CEO Linda Marbán on Q2 2022 Results Earnings Call TranscriptN/A
2022-08-09 20:06 ESTNewsCapricor Therapeutics Q2 Earnings PreviewN/A
2022-06-28 01:00 ESTNewsCapricor posts statistically significant data for DMD candidate in open-label trialN/A
2022-05-11 01:15 ESTNewsCapricor Therapeutics GAAP EPS of -$0.32N/A
2022-05-11 01:15 ESTNewsCapricor Therapeutics, Inc. (CAPR) CEO Linda Marban on Q1 2022 Results - Earnings Call TranscriptN/A
2022-03-28 16:40 ESTNewsCapricor Therapeutics down 24% following COVID-19 mid-stage trial results (updated)N/A
2022-03-11 08:26 ESTNewsCapricor Therapeutics, Inc. (CAPR) CEO Linda Marban On Q4 2021 Results - Earnings Call TranscriptN/A
2022-01-25 10:04 ESTNewsCapricor jumps 12% after CAP-1002 commercialization deal in U.S. for treatment of DMDN/A
2021-12-13 16:39 ESTNewsCapricor Therapeutics provides key updates on its COVID-19 vaccine programsN/A
2021-11-10 04:09 ESTNewsCapricor Therapeutics EPS beats by $0.06N/A
2021-11-10 04:08 ESTNewsCapricor Therapeutics, Inc. (CAPR) CEO Linda Marbán on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-09 05:10 ESTNewsCapricor Therapeutics Q3 2021 Earnings PreviewN/A
2021-09-25 19:24 ESTNewsCapricor Therapeutics Announces Another 'Final' 12-Month P2 Duchenne Muscular Dystrophy Trial ResultN/A
2021-09-24 23:37 ESTNewsCapricor jumps 17% on positive CAP-1002 data from mid-stage duchenne muscular dystrophy studyN/A
2021-09-02 16:11 ESTNewsCapricor shares up 6 % as it will present final data on muscular dystrophy candidate late SeptemberN/A
2021-08-13 10:16 ESTNewsCapricor Therapeutics EPS beats by $0.02, misses on revenueN/A
2021-08-13 10:15 ESTNewsCapricor Therapeutics, Inc. (CAPR) CEO Linda Marbán on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-20 22:51 ESTNewsCapricor Therapeutics slumps 9% on $75M stock offeringN/A
2021-04-30 07:24 ESTNewsCapricor shares rise on license agreement with Johns Hopkins UniversityN/A
2021-03-18 04:19 ESTFinancialsCompany financials have been released.Neutral
2021-03-13 03:16 ESTFinancialsCompany financials have been released.Neutral
2021-03-12 07:18 ESTEarnings EstimateAn EPS average of -$1.07 is estimated for the 2022 year.Sell
2021-03-12 00:43 ESTNewsCapricor Therapeutics EPS misses by $0.01N/A
2021-03-12 00:43 ESTNewsCapricor Therapeutics' (CAPR) CEO Linda Marbán on Q4 2020 Results - Earnings Call TranscriptN/A
2021-03-09 13:49 ESTNewsCapricor Therapeutics updates on COVID-19 vaccine pre-clinical studyN/A
2021-02-10 08:09 ESTNewsCapricor Therapeutics - Shockingly Undervalued With Imminent Catalysts In PlayN/A
2021-02-01 10:47 ESTNewsCapricor signs intellectual property license for COVID-19 serology test platformN/A
2021-01-25 03:17 ESTAnalyst RatingThe Analyst Target Price has increased from $10.5 to $12.Buy
2021-01-20 01:02 ESTNewsCapricor announces positive findings from collaboration with Cedars-Sinai Medical Center researchersN/A
2021-01-12 20:54 ESTNewsCapricor and Lonza tie up in DMD developmentN/A
2020-12-13 03:26 ESTFinancialsCompany financials have been released.Neutral
2020-11-24 15:54 ESTNewsDosing underway in Capricor Therapeutics' mid-stage CAP-1002 study in COVID-19N/A
2020-11-18 03:20 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 03:25 ESTFinancialsCompany financials have been released.Neutral
2020-11-15 11:31 ESTFinancialsCompany financials have been released.Neutral
2020-11-14 03:28 ESTFinancialsCompany financials have been released.Neutral
2020-11-13 22:56 ESTNewsCapricor Therapeutics, Inc's (CAPR) CEO Linda Marbán on Q3 2020 Results - Earnings Call TranscriptN/A
2020-11-12 19:06 ESTNewsCapricor Therapeutics reports Q3 resultsN/A
2020-11-01 17:26 ESTFinancialsCompany financials have been released.Neutral

About Capricor Therapeutics, Inc (CAPR):

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy (DMD), and other rare disorders. The company's development stage drug candidates for cardiosphere-derived cells include CAP-1002, a cardiac cell derived therapy, which is in phase II clinical trial for the treatment of patients with late-stage DMD; and completed various trials investigating the use of CAP-1002 for the treatment of cardiac conditions, including heart failure and post myocardial infarction with cardiac dysfunction. It is also developing CAP-2003 that is in pre-clinical development for the treatment of inflammatory conditions. Capricor collaborates with Lonza for the development of CAP-1002, its cell therapy candidate for the treatment of Duchenne muscular dystrophy and other indications. The company was founded in 2005 and is headquartered in Beverly Hills, California.

CAPR Quotes by TradingView

See Advanced Chart

General

  • Name Capricor Therapeutics, Inc
  • Symbol CAPR
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Last Split Factor1:10
  • Last Split Date2019-06-05
  • Fiscal Year EndDecember
  • IPO Date2007-02-13
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.capricor.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 149.52
  • Price/Book (Most Recent Quarter) 4.13
  • Enterprise Value Revenue 190.86
  • Enterprise Value EBITDA 0.03
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.00
  • Next Year EPS Estimate -$1.06
  • Operating Margin -4413%
  • Return on Assets -37%
  • Return on Equity -78%
  • Revenue 310250
  • Earnings Per Share -$3.74
  • Revenue Per Share $0.02
  • Gross Profit -8146750
  • Quarterly Earnings Growth -74%
View More

Highlights

  • Market Capitalization 118.78 million
  • EBITDA -11929662
  • Analyst Target Price $12
  • Book Value Per Share $1.37
View More

Share Statistics

  • Shares Outstanding 22.8 million
  • Shares Float 19.99 million
  • % Held by Insiders 253%
  • % Held by Institutions 6.2%
  • Shares Short 345150
  • Shares Short Prior Month 489136
  • Short Ratio 0.36
  • Short % of Float 2%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • Beta 6.47
  • 52 Week High $12.32
  • 52 Week Low $0.96
  • 50 Day Moving Average 6.37
  • 200 Day Moving Average 5.05
View More

Dividends

  • Dividend Date 2019-06-05
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Capricor Therapeutics, Inc (CAPR) Dividend Calendar:

CAPR's last dividend payment was made to shareholders on June 5, 2019.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Capricor Therapeutics, Inc (CAPR) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-11$N/A-$0.21-$0.20-5%
2020-09-302020-11-12$N/A-$0.20-$0.3745.95%
2020-06-302020-08-06$N/A-$0.23-$0.3432.35%
2020-03-312020-05-13$185693-$0.30-$0.3616.67%
2019-12-312020-03-18$222100-$0.34-$0.340%
2019-09-302019-11-07$142071-$0.43-$0.6836.76%
2019-06-302019-08-06$410353-$0.59-$0.8026.25%
2019-03-312019-05-13$230504-$0.80-$1.1027.27%
2018-12-312019-03-28$648082-$1.10-$1.6031.25%
2018-09-302018-11-13$219247-$1.40-$1.453.45%
2018-06-302018-08-09$403960-$1.40-$1.25-12%
2018-03-312018-05-10$400066-$1.40-$1.20-16.67%
2017-12-312018-03-14$475000$4.20-$1.00520%
2017-09-302017-11-08$314000-$1.20-$1.9036.84%
2017-06-302017-08-10$996000-$1.60-$1.8011.11%
2017-03-312017-05-15$881000-$1.70-$1.50-13.33%
2016-12-312017-03-15$907000-$2.10-$2.7022.22%
2016-09-302016-11-10$747000-$2.90-$2.65-9.43%
2016-06-302016-08-15$1.13 million-$2.60-$2.40-8.33%
2016-03-312016-05-12$1.22 million-$2.60-$1.90-36.84%
2015-12-312016-03-17$1.12 million-$2.10-$1.90-10.53%
2015-09-302015-11-12$1.32 million-$0.18-$0.2630.77%
2015-06-302015-08-13$1.29 million-$0.19-$0.2626.92%
2015-03-312015-05-12$1.79 million-$0.23-$0.14-64.29%
2014-12-312015-03-16$1.4 million-$0.16-$0.13-23.08%
2014-09-302014-11-14$1.3 million-$0.13-$0.2240.91%
2014-06-302014-08-14$1.04 million-$1.31
2014-03-312014-05-15$1.04 million-$1.04
2013-12-312014-03-17$503233-$6.39
2013-09-302013-11-15$80000-$4.02
2013-06-302013-08-15$190000-$6.94
2013-03-312013-06-21$233000-$5.61
2012-12-312013-03-12$2.03 million-$2.39
2012-09-302012-11-12$-2423235-$6.57
2012-06-302012-08-13$N/A-$4.11
2012-03-312012-05-15$195500-$20.00-$15.00-33.33%
2011-12-312012-03-13-$22.29
2011-09-302011-11-14$813000-$15.00-$7.50-100%
2011-06-302011-08-15$346000-$15.00-$5.00-200%
2011-03-312011-05-16-$15.00-$10.00-50%
2010-12-312011-03-14-$10.00-$21.6753.85%
2010-09-302010-11-12-$25.00-$23.33-7.16%
2010-06-302010-08-16-$25.00-$33.3324.99%
2010-03-312010-05-14-$35.00-$28.33-23.54%
2009-12-312010-03-03-$30.00-$25.00-20%
2009-09-302009-11-12-$40.00-$25.00-60%
2009-06-302009-08-13-$50.00-$37.50-33.33%
2009-03-312009-05-14-$35.00-$58.3340%
2008-12-312009-03-09-$60.00-$65.007.69%
2008-09-302008-11-13-$70.00-$78.3310.63%
2008-06-302008-08-14-$80.00-$57.50-39.13%
2008-03-312008-05-15-$65.00-$55.00-18.18%
2007-12-312008-03-13-$50.00-$95.0047.37%
2007-09-302007-11-28-$173.63
2006-12-312006-12-31-$6.69
2006-09-302006-09-30-$23.16
2006-06-302006-06-30-$5.98
2006-03-312006-03-31-$4.79
2005-09-302005-09-30-$2.28
2005-06-302005-06-30-$1.95
2005-03-312005-03-31-$3.57
2004-12-312004-12-31-$6.14
2004-09-302004-09-30-$2.33
2004-06-302004-06-30-$1.90
2004-03-312004-03-31-$1.64
2003-12-312003-12-31-$3.57
2003-09-302003-09-30-$0.06
2003-06-302003-06-30-$4.61
2003-03-312003-03-31-$2.46
2002-12-312002-12-31-$2.50
2002-09-302002-09-30-$5.67
2002-06-302002-06-30-$6.25

Capricor Therapeutics, Inc (CAPR) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Capricor Therapeutics, Inc (CAPR) Chart:

Capricor Therapeutics, Inc (CAPR) News:

Below you will find a list of latest news for Capricor Therapeutics, Inc (CAPR) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Capricor Therapeutics, Inc (CAPR) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-03-212.512.4CALL0 161364.91TRUE00
2025-03-21510.38CALL300 806273.73TRUE10.380
2025-03-217.57.94CALL0 1907238.98TRUE00
2025-03-21106.05CALL15 774196.69TRUE0.150.03
2025-03-2112.54.4CALL6 765186.57TRUE-0.1-0.02
2025-03-21153.2CALL128 1942185.17TRUE0.20.07
2025-03-2117.52CALL84 10074165.89FALSE-0.15-0.07
2025-03-21201.36CALL16 3516164.62FALSE0.060.05
2025-03-2122.50.76CALL17 313151.96FALSE-0.02-0.03
2025-03-21250.5CALL17 5933152.19FALSE0.10.25
2025-03-21300.25CALL10 2299157.04FALSE0.050.25
2025-03-21350.2CALL0 176164.54FALSE00
2025-03-21400.05CALL100 526155.21FALSE00
2025-03-212.50.05PUT1 947327.51FALSE0.050
2025-03-2150.33PUT3 4344291.9FALSE0.080.32
2025-03-217.50.65PUT31 2937257.5FALSE0.10.18
2025-03-21101.3PUT137 2665219.44FALSE0.10.08
2025-03-2112.52PUT25 2221207.37FALSE20
2025-03-21152.9PUT6 1128178.91FALSE-0.1-0.03
2025-03-2117.54.5PUT1 63177.85TRUE-0.35-0.07
2025-03-21207.82PUT0 121167.64TRUE00
2025-03-2122.510.65PUT0 22144.31TRUE00
2025-03-212511.48PUT0 16143.72TRUE00
2025-03-213013.58PUT0 70165.74TRUE00
2025-03-213520.1PUT0 10TRUE00
2025-03-21400PUT0 0308.86TRUE00
2025-04-172.50CALL0 0305.09TRUE00
2025-04-1750CALL0 0208.96TRUE00
2025-04-177.50CALL0 0175.42TRUE00
2025-04-17100CALL0 0171.25TRUE00
2025-04-1712.50CALL0 0148.63TRUE00
2025-04-17153.4CALL10 0141.21TRUE3.40
2025-04-1717.52.45CALL1 0137.68FALSE2.450
2025-04-17200CALL0 0121.89FALSE00
2025-04-1722.50CALL0 0131.05FALSE00
2025-04-17250.65CALL2 0118.45FALSE0.650
2025-04-17300CALL0 0104.42FALSE00
2025-04-172.50PUT0 0236.09FALSE00
2025-04-1750PUT0 0509.72FALSE00
2025-04-177.50PUT0 0188.5FALSE00
2025-04-17100PUT0 0158.63FALSE00
2025-04-1712.50PUT0 0146.25FALSE00
2025-04-17153PUT5 0134.23FALSE30
2025-04-1717.50PUT0 0144.17TRUE00
2025-04-17200PUT0 0133.48TRUE00
2025-04-1722.50PUT0 0119.66TRUE00
2025-04-17250PUT0 0125.61TRUE00
2025-04-17300PUT0 0161.24TRUE00
2025-06-202.511.7CALL0 5135.39TRUE00
2025-06-20510.52CALL300 1702148.07TRUE10.520
2025-06-207.57.75CALL0 50127.73TRUE00
2025-06-20106.67CALL4 1093122.7TRUE6.670
2025-06-2012.55CALL1 2114110.45TRUE0.450.1
2025-06-20153.95CALL20 823111.89TRUE0.050.01
2025-06-2017.52.75CALL3 328101.58FALSE0.290.12
2025-06-20201.91CALL0 585100.89FALSE00
2025-06-2022.51.75CALL0 31799.78FALSE00
2025-06-20251CALL0 317102.79FALSE00
2025-06-20300.9CALL0 171686.68FALSE00
2025-06-20350.35CALL0 368101.01FALSE00
2025-06-20400.32CALL0 2123113.19FALSE00
2025-06-202.50.15PUT0 587173.79FALSE00
2025-06-2050.6PUT0 23157.51FALSE00
2025-06-207.50.85PUT0 246134.94FALSE00
2025-06-20101.44PUT0 350123.41FALSE00
2025-06-2012.52.45PUT0 229112.78FALSE00
2025-06-20153.35PUT8 309104FALSE-0.45-0.12
2025-06-2017.54.84PUT0 320103.5TRUE00
2025-06-20209.31PUT0 23899.72TRUE00
2025-06-2022.58.9PUT0 247104.45TRUE00
2025-06-202513.5PUT0 110102.38TRUE00
2025-06-203017.13PUT0 4887.28TRUE00
2025-06-20350PUT0 00TRUE00
2025-06-204027PUT0 0149.57TRUE00
2025-09-192.50CALL0 0201.73TRUE00
2025-09-19511.4CALL0 2133.01TRUE00
2025-09-197.56.92CALL0 1139.74TRUE00
2025-09-19106.72CALL0 24125.54TRUE00
2025-09-1912.55.5CALL0 18123.77TRUE00
2025-09-19155.55CALL679 130121.2TRUE5.550
2025-09-1917.54.61CALL4 116116.74FALSE0.210.05
2025-09-19204.25CALL0 80120.39FALSE00
2025-09-1922.53.7CALL0 73118.59FALSE00
2025-09-19253.1CALL0 39117.18FALSE00
2025-09-19302.1CALL0 27117.85FALSE00
2025-09-192.50PUT0 4175.7FALSE00
2025-09-1950PUT0 0130.61FALSE00
2025-09-197.51.6PUT0 14136.39FALSE00
2025-09-19102.63PUT0 22135.02FALSE00
2025-09-1912.53.91PUT0 30127.43FALSE00
2025-09-19154.91PUT0 1128.09FALSE00
2025-09-1917.57.5PUT0 3122.76TRUE00
2025-09-19208.5PUT0 1121.77TRUE00
2025-09-1922.511.1PUT0 6122.93TRUE00
2025-09-192512.7PUT0 2116.75TRUE00
2025-09-19300PUT0 0115.15TRUE00
2026-01-162.511.9CALL0 40138.84TRUE00
2026-01-1659.8CALL0 2122.03TRUE00
2026-01-167.59.8CALL1 25126.15TRUE9.80
2026-01-16108.22CALL200 245112.8TRUE0.060.01
2026-01-1612.56.65CALL0 5114.49TRUE00
2026-01-16156.2CALL0 170110.63TRUE00
2026-01-1617.56CALL0 55118.26FALSE00
2026-01-16205CALL0 68119.56FALSE00
2026-01-1622.54.45CALL0 8116.66FALSE00
2026-01-16254.25CALL0 12114.5FALSE00
2026-01-16303.6CALL2 296114.54FALSE00
2026-01-162.50PUT0 0157.71FALSE00
2026-01-1650.8PUT0 100116.65FALSE00
2026-01-167.51.9PUT0 15133.22FALSE00
2026-01-16103.19PUT10 57125.89FALSE-0.01-0
2026-01-1612.54.67PUT0 20124.49FALSE00
2026-01-16156.3PUT250 1124.16FALSE6.30
2026-01-1617.50PUT0 0122.48TRUE00
2026-01-16200PUT0 0114.57TRUE00
2026-01-1622.50PUT0 0114.64TRUE00
2026-01-16250PUT0 0119.63TRUE00
2026-01-16300PUT0 0117.76TRUE00
2027-01-152.512.25CALL0 1112.3TRUE00
2027-01-1550CALL0 099.53TRUE00
2027-01-157.50CALL0 089.64TRUE00
2027-01-151010.5CALL0 2893.82TRUE00
2027-01-1512.59.2CALL0 30196.19TRUE00
2027-01-15158.11CALL0 3694.46TRUE00
2027-01-1517.58CALL0 26596.63FALSE00
2027-01-15206.72CALL0 3096.8FALSE00
2027-01-1522.56.91CALL0 1394.83FALSE00
2027-01-15255.6CALL0 2597.42FALSE00
2027-01-15305.2CALL0 8102.04FALSE00
2027-01-152.50PUT0 0139.18FALSE00
2027-01-1550PUT0 090.12FALSE00
2027-01-157.52.65PUT0 1104.19FALSE00
2027-01-15104.84PUT0 3103.77FALSE00
2027-01-1512.55.8PUT0 3107.3FALSE00
2027-01-15157.34PUT0 599.4FALSE00
2027-01-1517.50PUT0 099.43TRUE00
2027-01-152012.5PUT0 10100.38TRUE00
2027-01-1522.50PUT0 0101.02TRUE00
2027-01-15250PUT0 0102.22TRUE00
2027-01-15300PUT0 0105.96TRUE00

Latest CAPR Trades:

Date Shares Price
Jun 13, 2022 7:58 PM EST62$3.88
Jun 13, 2022 7:58 PM EST5$3.8
Jun 13, 2022 7:59 PM EST100$3.8
Jun 13, 2022 7:59 PM EST100$3.79
Jun 13, 2022 7:59 PM EST50$3.79

Capricor Therapeutics, Inc (CAPR) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-17S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920074227/0001104659-20-074227-index.htm
2018-10-31UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1133869/000000000018034036/0000000000-18-034036-index.htm
2019-12-09UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1133869/000000000019016215/0000000000-19-016215-index.htm
2020-05-14UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1133869/000000000020004293/0000000000-20-004293-index.htm
2019-12-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1133869/000091957419007837/0000919574-19-007837-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465919061080/0001104659-19-061080-index.htm
2019-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000110465919061773/0001104659-19-061773-index.htm
2019-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465919063785/0001104659-19-063785-index.htm
2019-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465919064252/0001104659-19-064252-index.htm
2019-12-05S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1133869/000110465919070066/0001104659-19-070066-index.htm
2019-12-13S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1133869/000110465919072396/0001104659-19-072396-index.htm
2019-12-13S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1133869/000110465919072626/0001104659-19-072626-index.htm
2019-12-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1133869/000110465919072629/0001104659-19-072629-index.htm
2019-12-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465919073161/0001104659-19-073161-index.htm
2019-12-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465919073600/0001104659-19-073600-index.htm
2019-12-19424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1133869/000110465919074049/0001104659-19-074049-index.htm
2019-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465919074247/0001104659-19-074247-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465919074513/0001104659-19-074513-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465919074514/0001104659-19-074514-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465919074516/0001104659-19-074516-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022098/0001104659-20-022098-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022099/0001104659-20-022099-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022100/0001104659-20-022100-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022101/0001104659-20-022101-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022102/0001104659-20-022102-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022103/0001104659-20-022103-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022104/0001104659-20-022104-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022105/0001104659-20-022105-index.htm
2020-02-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920022110/0001104659-20-022110-index.htm
2020-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920031538/0001104659-20-031538-index.htm
2020-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920034994/0001104659-20-034994-index.htm
2020-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920035320/0001104659-20-035320-index.htm
2020-03-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920038468/0001104659-20-038468-index.htm
2020-03-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1133869/000110465920039272/0001104659-20-039272-index.htm
2020-04-17DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920047790/0001104659-20-047790-index.htm
2020-05-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920056292/0001104659-20-056292-index.htm
2020-05-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1133869/000110465920056303/0001104659-20-056303-index.htm
2020-05-07S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1133869/000110465920058189/0001104659-20-058189-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920058192/0001104659-20-058192-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920060449/0001104659-20-060449-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920060930/0001104659-20-060930-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920061570/0001104659-20-061570-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920062419/0001104659-20-062419-index.htm
2020-05-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1133869/000110465920062458/0001104659-20-062458-index.htm
2020-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000110465920062698/0001104659-20-062698-index.htm
2020-05-19424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1133869/000110465920063822/0001104659-20-063822-index.htm
2020-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920066994/0001104659-20-066994-index.htm
2020-06-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071410/0001104659-20-071410-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071413/0001104659-20-071413-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071415/0001104659-20-071415-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071417/0001104659-20-071417-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071419/0001104659-20-071419-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071420/0001104659-20-071420-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071421/0001104659-20-071421-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071423/0001104659-20-071423-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920071426/0001104659-20-071426-index.htm
2020-06-17S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920074227/0001104659-20-074227-index.htm
2020-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920087909/0001104659-20-087909-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920091413/0001104659-20-091413-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000110465920092415/0001104659-20-092415-index.htm
2020-08-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000110465920098381/0001104659-20-098381-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000110465920109138/0001104659-20-109138-index.htm
2017-10-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420417053252/0001144204-17-053252-index.htm
2017-10-19424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1133869/000114420417053253/0001144204-17-053253-index.htm
2017-10-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420417053990/0001144204-17-053990-index.htm
2017-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420417057263/0001144204-17-057263-index.htm
2017-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000114420417058512/0001144204-17-058512-index.htm
2017-11-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420417059277/0001144204-17-059277-index.htm
2017-11-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420417061266/0001144204-17-061266-index.htm
2017-12-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420417063248/0001144204-17-063248-index.htm
2017-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420417064330/0001144204-17-064330-index.htm
2017-12-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420417065088/0001144204-17-065088-index.htm
2018-01-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000266/0001144204-18-000266-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000853/0001144204-18-000853-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000854/0001144204-18-000854-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000856/0001144204-18-000856-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000857/0001144204-18-000857-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000859/0001144204-18-000859-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000860/0001144204-18-000860-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000861/0001144204-18-000861-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000862/0001144204-18-000862-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000863/0001144204-18-000863-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000864/0001144204-18-000864-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000865/0001144204-18-000865-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418000868/0001144204-18-000868-index.htm
2018-02-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418005594/0001144204-18-005594-index.htm
2018-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418009043/0001144204-18-009043-index.htm
2018-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418014063/0001144204-18-014063-index.htm
2018-03-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418014635/0001144204-18-014635-index.htm
2018-03-2210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1133869/000114420418016468/0001144204-18-016468-index.htm
2018-04-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418022479/0001144204-18-022479-index.htm
2018-05-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418025173/0001144204-18-025173-index.htm
2018-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418027107/0001144204-18-027107-index.htm
2018-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000114420418027786/0001144204-18-027786-index.htm
2018-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418033770/0001144204-18-033770-index.htm
2018-07-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420418039922/0001144204-18-039922-index.htm
2018-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418043267/0001144204-18-043267-index.htm
2018-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000114420418043686/0001144204-18-043686-index.htm
2018-10-24S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1133869/000114420418055035/0001144204-18-055035-index.htm
2018-11-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418056889/0001144204-18-056889-index.htm
2018-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418059340/0001144204-18-059340-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000114420418059980/0001144204-18-059980-index.htm
2018-12-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420418066148/0001144204-18-066148-index.htm
2019-01-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419000167/0001144204-19-000167-index.htm
2019-01-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419002173/0001144204-19-002173-index.htm
2019-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419005129/0001144204-19-005129-index.htm
2019-03-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419016629/0001144204-19-016629-index.htm
2019-03-2910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1133869/000114420419016787/0001144204-19-016787-index.htm
2019-04-0110-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1133869/000114420419017194/0001144204-19-017194-index.htm
2019-04-19PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419020402/0001144204-19-020402-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419022029/0001144204-19-022029-index.htm
2019-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419025600/0001144204-19-025600-index.htm
2019-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000114420419026041/0001144204-19-026041-index.htm
2019-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419029338/0001144204-19-029338-index.htm
2019-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419029669/0001144204-19-029669-index.htm
2019-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419031589/0001144204-19-031589-index.htm
2019-07-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419034627/0001144204-19-034627-index.htm
2019-07-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1133869/000114420419034690/0001144204-19-034690-index.htm
2019-07-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419034770/0001144204-19-034770-index.htm
2019-07-17S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1133869/000114420419034954/0001144204-19-034954-index.htm
2019-07-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419035262/0001144204-19-035262-index.htm
2019-07-22424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1133869/000114420419035263/0001144204-19-035263-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419037875/0001144204-19-037875-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133869/000114420419038387/0001144204-19-038387-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419038994/0001144204-19-038994-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419038995/0001144204-19-038995-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419038996/0001144204-19-038996-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419038997/0001144204-19-038997-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419038998/0001144204-19-038998-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419038999/0001144204-19-038999-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419039000/0001144204-19-039000-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133869/000114420419039001/0001144204-19-039001-index.htm
2019-08-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419040654/0001144204-19-040654-index.htm
2019-08-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419042160/0001144204-19-042160-index.htm
2019-08-29424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1133869/000114420419042161/0001144204-19-042161-index.htm
2019-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133869/000114420419047446/0001144204-19-047446-index.htm
2019-07-18EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1133869/999999999519001637/9999999995-19-001637-index.htm
2019-12-17EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1133869/999999999519002841/9999999995-19-002841-index.htm
2020-05-19EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1133869/999999999520001205/9999999995-20-001205-index.htm
2018-04-19CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1133869/999999999718004982/9999999997-18-004982-index.htm
2018-08-29CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1133869/999999999718007502/9999999997-18-007502-index.htm

Capricor Therapeutics, Inc (CAPR) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Capricor Therapeutics, Inc (CAPR). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 253%
Institutional Ownership: 620%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2017-10-23Louis ManzoDirectorBuy20,748.000.163,319.68159,132.00https://www.sec.gov/Archives/edgar/data/1133869/000114420417053990/0001144204-17-053990-index.htm
2019-12-17Frank LitvackDirectorBuy20,391.0020,391.00https://www.sec.gov/Archives/edgar/data/1133869/000110465919074516/0001104659-19-074516-index.htm
2017-12-22Rachel SmithVice President of R&DBuy20,748.000.163,319.6820,748.00https://www.sec.gov/Archives/edgar/data/1133869/000114420418000868/0001144204-18-000868-index.htm
2019-12-17David B MusketDirectorBuy20,391.0022,891.00https://www.sec.gov/Archives/edgar/data/1133869/000110465919074514/0001104659-19-074514-index.htm
2019-12-17Louis ManzoDirectorBuy20,391.0036,304.00https://www.sec.gov/Archives/edgar/data/1133869/000110465919074513/0001104659-19-074513-index.htm
2020-09-24Louis ManzoDirectorBuy8,299.003.7030,706.3044,603.00https://www.sec.gov/Archives/edgar/data/1133869/000110465920109138/0001104659-20-109138-index.htm
2020-07-27Linda MarbanCHIEF EXECUTIVE OFFICERBuy41,497.003.70153,538.9062,367.00https://www.sec.gov/Archives/edgar/data/1133869/000110465920087909/0001104659-20-087909-index.htm